By Martin Smith, Chief Technology Officer and Rick Morris, Senior Vice President of R&D, Pall Biotech
Pertinent break-through technology is born at the interface of an inventor’s passion and market necessity. In the bioprocessing world, regulations have changed, driving the need for higher quality and improved process monitoring. At the same time, there is a trend towards greater process efficiencies and lower manufacturing costs. Vendors have to bear all of these drivers in mind when developing new technologies.
Martin Smith, Chief Technology Officer at Pall, and Rick Morris, Senior Vice President of R&D at Pall Biotech, explain how vendors contribute to improving and enhancing bioprocess operations.